K Kollia
First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5T and 7T
Kollia K, Maderwald S, Putzki N, Schlamann M, Theysohn J, Kraff O, Ladd M, Forsting M, Wanke I. First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5T and 7T. AJNR. American journal of neuroradiology 2009; 30:699-702.
01.04.2009First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5T and 7T
01.04.2009AJNR. American journal of neuroradiology 2009; 30:699-702
Kollia K, Maderwald S, Putzki Norman, Schlamann M, Theysohn J M, Kraff O, Ladd M E, Forsting M, Wanke I
Natalizumab is effective as second line therapy in the treatment of relapsing remitting multiple sclerosis
Putzki N, Kollia K, Woods S, Igwe E, Diener H, Limmroth V. Natalizumab is effective as second line therapy in the treatment of relapsing remitting multiple sclerosis. European journal of neurology : the official journal of the European Federation of Neurological Societies 2009; 16:424-6.
01.03.2009Natalizumab is effective as second line therapy in the treatment of relapsing remitting multiple sclerosis
01.03.2009European journal of neurology : the official journal of the European Federation of Neurological Societies 2009; 16:424-6
Putzki Norman, Kollia K, Woods S, Igwe E, Diener H C, Limmroth V